Related Experiment Video
Updated: Jul 13, 2025

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension
Jiaxin Hu1, Wenchi Sha1, Shuangshuang Yuan1
1Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Abstract:
The microtubule-associated protein tau is an intrinsically disordered protein containing a few short and transient secondary structures. Tau physiologically associates with microtubules (MTs) for its stabilization and detaches from MTs to regulate its dynamics. Under pathological conditions, tau is abnormally modified, detaches from MTs, and forms protein aggregates in neuronal and glial cells. Tau protein aggregates can be found in a number of devastating neurodegenerative diseases known as "tauopathies", such as Alzheimer's disease (AD), frontotemporal dementia (FTD), corticobasal degeneration (CBD), etc. However, it is still unclear how the tau protein is compacted into ordered protein aggregates, and the toxicity of the aggregates is still debated. Fortunately, there has been considerable progress in the study of tau in recent years, particularly in the understanding of the intercellular transmission of pathological tau species, the structure of tau aggregates, and the conformational change events in the tau polymerization process. In this review, we summarize the concepts of tau protein aggregation and discuss the views on tau protein transmission and toxicity.
Insights
Microtubule-associated protein tau aggregates in neurodegenerative diseases like Alzheimer's. This review covers tau protein aggregation, transmission, and toxicity, advancing understanding of tauopathies.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Microtubule-associated protein tau (tau) is intrinsically disordered, interacting with microtubules (MTs).
- Pathological tau modification leads to detachment from MTs and aggregation in neurodegenerative diseases (tauopathies).
- Tauopathies include Alzheimer's disease (AD), frontotemporal dementia (FTD), and corticobasal degeneration (CBD).
Purpose of the Study:
- To review current understanding of tau protein aggregation mechanisms.
- To discuss the intercellular transmission of pathological tau species.
- To explore the structural and conformational aspects of tau polymerization and aggregate toxicity.
Main Methods:
- Literature review of recent advancements in tau protein research.
- Synthesis of findings on tau structure, aggregation, and intercellular spread.
- Discussion of ongoing debates regarding tau aggregate toxicity.
Main Results:
- Significant progress has been made in understanding tau transmission and aggregate structures.
- Conformational changes during tau polymerization are key to aggregate formation.
- The precise mechanisms of tau aggregation and the toxicity of these aggregates remain areas of active investigation.
Conclusions:
- Tau aggregation is central to tauopathies, but the exact process and toxicity are still debated.
- Understanding tau transmission and aggregation is crucial for developing therapeutic strategies.
- Further research into tau's conformational dynamics and intercellular spread is needed.
Related Concept Videos
Assembly of Complex Microtubule Structures
Microtubule Associated Proteins (MAPs)
Destabilization of Microtubules
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Microtubule Instability
Drugs that Stabilize Microtubules

